Skip to main content

Table 3 Management of 26 patients with Multisystem Inflammatory Syndrome in Children in Michigan, April 2020 – February 2021

From: A descriptive study on multisystem inflammatory syndrome in children in a single center in West Michigan

Treatment
  Total (%) Group 1 (PICU) (%) Group 2 (non-PICU) (%) p values
Total 26 15 11
Inotropesa 12 (46.2) 12 (80) 0 (0) 0.0001*
Aspirin 25 (96.2) 15 (100) 10 (90.9) 0.4231
Low-molecular weight heparin 12 (46.2) 9 (60) 3 (27.3) 0.0982
Heparin 5 (19.2) 5 (33.3) 0 (0) 0.0527
IVIG 25 (96.2) 15 (100) 10 (90.9) 0.4231
Steroids 22 (84.6) 13 (86.7) 9 (81.8) 1.0
Steroid pulse 7 (26.9) 6 (40) 1 (9.1) 0.1783
Anakinra 13 (50) 10 (66.7) 3 (27.3) 0.0472*
Infliximab 1 (3.9) 1 (6.7) 0 (0) 1.0
  1. IVIG Intravenous immune globulin
  2. aThis included epinephrine, norepinephrine, vasopressin, and/or milrinone
  3. *significant p value (≤0.05)